PLOD2 and neoplasm: Additionally, the collagen-modifying enzyme procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2), which is overexpressed in many tumors relative to normal tissues, has been shown to promote immune evasion in UPS, contributing to tumor metastasis and CD8+ T cell dysfunction.